Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
renal denervation
MedTech
Medtronic claims long-sought FDA approval in renal denervation
Medtronic claimed the FDA's second green light in renal denervation this month, as it competes with Recor for a potential multibillion-dollar market.
Conor Hale
Nov 20, 2023 10:21am
Recor claims 1st FDA renal denervation approval for hypertension
Nov 8, 2023 10:07am
FDA panel backs ReCor, shuns Medtronic in renal denervation
Aug 24, 2023 11:28am
ReCor Medical taps Siemens Healthineers alum as CEO
Jan 3, 2023 12:04pm
Medtronic, ReCor back renal denervation approach to hypertension
Sep 20, 2022 2:51pm
ACC: Medtronic touts 3-year renal denervation data
Apr 4, 2022 12:45pm
